{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:12:15Z","timestamp":1792977135716,"version":"4.5.0"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Ophthalmology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold>Proliferative feline eosinophilic keratitis is a chronic keratopathy caused by a suspected immune mediated response to an unknown antigenic stimulus. The purpose of this study is to demonstrate the efficacy of topical 1.5% cyclosporine solution in proliferative feline eosinophilic keratitis.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>Thirty\u2010five cats were treated topically with 1.5% cyclosporine A between 1997 and 2007. Eosinophilic keratitis was diagnosed by clinical appearance and evidence of eosinophils and\/or mast cells in corneal cytology. The patients were treated with topical cyclosporine (1.5%) twice (26 of 35, 74.3%) and three times (9 of 35, 25.7%) daily. The minimum period for follow\u2010up was 5\u00a0months.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>The age of the patients ranged from 2 to 13\u00a0years with a mean age of 6.0\u00a0years. Twenty\u2010two were neutered males, and 13 were females. The represented breeds were 30 DSH, 3 DLH, one Siamese and one Maine Coon. Cytologic examination of a corneal scrape revealed the presence of eosinophils in 34 of 35 specimens, and mast cells in 25 of 35 specimens. Improvement in the treated eyes was seen in 31 cats (88.6%). Four animals (11.4%) did not respond to the treatment with topical cyclosporine. Recurrences were seen in seven (22.6%) cases. Blepharitis was noted as an infrequent side effect.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold>Based on our findings, topical cyclosporine (1.5%) is an effective treatment of proliferative feline eosinophilic keratitis in the vast majority of cases. Recurrences were mainly associated with poor owner compliance. Chronic, often lifelong therapy with medications is thus recommended.<\/jats:p>","DOI":"10.1111\/j.1463-5224.2008.00679.x","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T09:02:52Z","timestamp":1236070972000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases"],"prefix":"10.1111","volume":"12","author":[{"given":"Amelie K.","family":"Spiess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloma","family":"Mayordomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1983.tb00418.x"},{"key":"e_1_2_5_3_2","first-page":"477","article-title":"Proliferative keratitis in a cat, a case report","volume":"20","author":"Pentlarge VW","year":"1984","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_5_4_2","first-page":"63","article-title":"Feline eosinophilic keratitis: a review of 15 clinical cases","volume":"23","author":"Paulsen M","year":"1987","journal-title":"Journal of the American Animal Hospital Association"},{"issue":"2","key":"e_1_2_5_5_2","first-page":"131","article-title":"Feline eosinophilic keratitis: a retrospective study of 54 Cases (1989\u20131994)","volume":"6","author":"Morgan RV","year":"1996","journal-title":"Veterinary Compendium of Ophthalmology"},{"issue":"3","key":"e_1_2_5_6_2","first-page":"21","article-title":"Chronic eosinophilic keratitis in the cat","volume":"9","author":"Brightman A.","year":"1979","journal-title":"Feline Practice"},{"issue":"6","key":"e_1_2_5_7_2","first-page":"49","article-title":"Corneal eosinophilic granuloma","volume":"9","author":"Kipnis R.","year":"1979","journal-title":"Feline Practice"},{"key":"e_1_2_5_8_2","first-page":"649","article-title":"Eosinophilic plaque involving eyelids of a cat","volume":"23","author":"Latimer C","year":"1987","journal-title":"Journal of the American Animal Hospital Association"},{"issue":"2","key":"e_1_2_5_9_2","first-page":"74","article-title":"Cytology and histopathology of feline eosinophilic keratitis","volume":"6","author":"Prasse KW","year":"1996","journal-title":"Veterinary Compendium of Ophthalmology"},{"issue":"7","key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2460\/ajvr.1998.59.07.856","article-title":"Detection of feline herpesvirus 1 DNA in corneas of cats with eosinophilic keratitis or corneal sequestration","volume":"59","author":"Nasisse MP","year":"1998","journal-title":"American Journal of Veterinary Research"},{"issue":"1","key":"e_1_2_5_11_2","first-page":"63","article-title":"Anti\u2010inflammatory therapy in herpesvirus keratoconjunctivitis","volume":"1","author":"Nasisse MP","year":"1991","journal-title":"Progress in Veterinary and Comparative Ophthalmology"},{"key":"e_1_2_5_12_2","volume-title":"Veterinary Ophthalmology","author":"Stiles J","year":"2007"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ctsap.2004.12.012"},{"key":"e_1_2_5_14_2","volume-title":"Veterinary Drug Handbook","author":"Plumb DC","year":"2008"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-5224.2001.00150.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.137.7.170"},{"key":"e_1_2_5_17_2","first-page":"725","volume-title":"Ocular Therapeutics","author":"Moore CP"},{"issue":"3","key":"e_1_2_5_18_2","first-page":"98","article-title":"Current therapy of canine keratoconjunctivitis sicca and rationale for change: treating the causal factors with topical cyclosporine","volume":"1","author":"Kaswan RL","year":"1989","journal-title":"Veterinary Focus"},{"issue":"3","key":"e_1_2_5_19_2","first-page":"653","article-title":"Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model","volume":"42","author":"Moore CP","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"8","key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2460\/javma.1991.199.08.1043","article-title":"Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Morgan RV","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"issue":"8","key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2460\/javma.1991.199.08.1039","article-title":"Clinical evaluation of 1% cyclosporine for treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Olivero DK","year":"1991","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_5_22_2","first-page":"58","article-title":"Management of keratoconjunctivitis sicca in dogs","author":"Wilkie D.","year":"1993","journal-title":"The Compendium"},{"issue":"25","key":"e_1_2_5_23_2","first-page":"635","article-title":"Comparison of topical cyclosporine and dexamethasone treatment of chronic superficial keratitis in dogs","volume":"137","author":"Williams DL","year":"1995","journal-title":"The Veterinary Record"},{"key":"e_1_2_5_24_2","first-page":"269","article-title":"Chronic superficial keratitis in dogs: a placebo controlled trial of topical cyclosporine treatment","volume":"1","author":"Jackson P","year":"1991","journal-title":"Progress in Vet and Comp Ophthalmology"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90111-J"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-072160561-6.50013-7"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.100.7.128"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-64-7-1491"},{"issue":"7","key":"e_1_2_5_29_2","first-page":"1170","article-title":"Effect of cyclosporine A on clinical and immunologic parameters in herpes simplex keratitis","volume":"28","author":"Meyers\u2010Elliot RH","year":"1987","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7","key":"e_1_2_5_30_2","first-page":"1362","article-title":"Ocular penetration of cyclosporine a. The rabbit eye","volume":"31","author":"BenEzra D","year":"1990","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.74.6.350"},{"issue":"2","key":"e_1_2_5_32_2","first-page":"125","article-title":"Lymphocyte proliferation and blood drug levels in dogs with keratoconjunctivitis sicca receiving longterm ocular cyclosporine","volume":"6","author":"Gilger BC","year":"1996","journal-title":"Veterinary and Comparative Ophthalmology"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198903000-00023"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-5224.1998.00039.x"}],"container-title":["Veterinary Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-5224.2008.00679.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1463-5224.2008.00679.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T01:11:48Z","timestamp":1710119508000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-5224.2008.00679.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1463-5224.2008.00679.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-5224.2008.00679.x","archive":["Portico"],"relation":{},"ISSN":["1463-5216","1463-5224"],"issn-type":[{"value":"1463-5216","type":"print"},{"value":"1463-5224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2009-03-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}